Join the Society for Epidemiologic Research (SER) and American Society of Preventive Oncology (ASPO) for a joint webinar! Members of all organizations are welcome to participate!
Thanks to working group members Katherine Reeves, Amy Trentham Dietz, Elizabeth Hibler, Andrew Olshan, and Shelley Tworoger for planning the events!
“Current Approaches and Applications in Investigating Gene/Environment Interactions”
Drs. Peter Kraft and Ulrike Peters
Date: September 4, 2019
Time: 12:00 – 1:00pm EST
Online Web Conference
Registration is now closed.
Evaluating gene X environment interactions are of increasing interest and importance in epidemiologic research. This webinar features two leaders in the field, Drs. Peter Kraft (Harvard T. H. Chan School of Public Health) and Ulrike Peters (Fred Hutchinson Cancer Research Center), who will review current methodology and provide illustrative examples of applications in cancer epidemiology.
Peter Kraft is Professor of Epidemiology and Biostatistics and Director of the Program in Genetic Epidemiology and Statistical Genetics at the Harvard T.H. Chan School of Public Health. His research concentrates on the design and analysis of genetic association studies, with particular emphasis on the genetic epidemiology of cancer. He has participated in many international consortia studying genetics and environmental exposures in relation to cancer risk over the last fifteen years, including the Breast and Prostate Cancer Cohort Consortium (BPC3); the NCI’s PanScan and Cancer Genetic Markers of Susceptibility (CGEMS) projects; the NCI’s “post-GWAS” GAME-ON consortium; the Breast Cancer Association Consortium (BCAC); and the Cancer Risk Estimates Related to Susceptibility Genes (CARRIERS) consortium, which is sequencing cancer predisposition genes in a large population-based breast cancer case-control sample. Read more
Dr. Ulrike “Riki” Peters, a molecular and genetic epidemiologist, is associate director of the Public Health Sciences Division at Fred Hutch. Her research focuses on the genetic epidemiology of colorectal cancer as well as the impact of race and ethnicity on underlying genetic risk factors for common, complex diseases. In 2007, Dr. Peters initiated the Genetics and Epidemiology of Colorectal Cancer Consortium, or GECCO, the world’s largest molecular and genetic consortium for colorectal cancer. The consortium involves researchers from more than 130 institutions around the world. Together, they identify novel genetic risk factors for colorectal cancer to create personalized screening strategies and better drug therapies. Using GECCO data, Dr. Peters and colleagues also study the interplay between genes and the environment on colorectal cancer risk via genome-wide association studies. Dr. Peters also leads research that utilizes data from the Women’s Health Initiative minority cohort to understand potential genetic contributions to health disparities.